Litcius/Paper detail

Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy

Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, Sounak Gupta, Onur Yıldırım, Samuel Murray, Devyn Taylor Coskey, Ritesh R. Kotecha, Chung‐Han Lee, Darren R. Feldman, Paul Russo, Sujata Patil, Robert J. Motzer, Jonathan Coleman, Jeremy C. Durack, Ying‐Bei Chen, Oğuz Akın, A. Ari Hakimi, Martin H. Voss

2022European Urology63 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRenal cell carcinomaNivolumabNephrectomyKidney cancerNephrologyAdverse effectSurgeryUrologyKidney diseaseInternal medicineKidneyCancerOncologyImmunotherapyRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy | Litcius